Table 3.
Adherence to performance measures.
| Quality Indicators (QI) | Eligible Patients, No. (%) a | Overall Adherence, % | Hospital Variation, Range (%) |
|---|---|---|---|
| QI1: Aspirin prescribed within 3h of hospital arrival | 1549 (58.17) | 73.08 | 62.11–85.81 |
| QI2: Beta-blockers within 12h of arrival | 785 (23.69) | 38.98 | 32.89–45.45 |
| QI3: Clopidogrel within 12h of arrival | 2408 (90.42) | 67.86 | 62.68–73.27 |
| QI4: Thrombolytics received within 30 min of hospital arrival | 971 (36.46) | 7.52 | 3.57–11.43 |
| QI5: ECG within 10 min of hospital arrival | 2663 (100.00) | 62.49 | 57.74–71.84 |
| QI6: Left ventricular function assessment | 2663 (100.00) | 62.79 | 56.33–67.53 |
| QI7: Coronary angiography performed during hospital stay | 2663 (100.00) | 66.35 | 60.85–71.78 |
| QI8: Primary PCI | 2366 (88.85) | 37.36 | 29.52–43.59 |
| Prescription filled post-discharge | |||
| QI9: Aspirin | 1549 (58.17) | 47.97 | 38.51–61.29 |
| QI10: Beta-blocker | 785 (29.48) | 22.29 | 10.94–34.21 |
| QI11: Clopidogrel | 2408 (90.42) | 45.35 | 35.36–53.59 |
| QI12: Statin | 2020 (75.85) | 36.39 | 30.11–41.76 |
| QI13: ACE inhibitor | 2567 (96.40) | 38.02 | 29.70–45.54 |
| Outcome indicators | |||
| In-hospital mortality | 2663 (100.00) | 8.56 | 5.56–12.50 |
Abbreviation: PCI, percutaneous coronary intervention. a Eligible patients are those with definite indications but no documented contraindications.